PREDICT: a method for inferring novel drug indications with application to personalized medicine

  title={PREDICT: a method for inferring novel drug indications with application to personalized medicine},
  author={Assaf Gottlieb and Gideon Y. Stein and Eytan Ruppin and Roded Sharan},
  journal={Molecular Systems Biology},
  pages={496 - 496}
Inferring potential drug indications, for either novel or approved drugs, is a key step in drug development. Previous computational methods in this domain have focused on either drug repositioning or matching drug and disease gene expression profiles. Here, we present a novel method for the large‐scale prediction of drug indications (PREDICT) that can handle both approved drugs and novel molecules. Our method is based on the observation that similar drugs are indicated for similar diseases, and… 

Prediction of new drug indications based on clinical data and network modularity

This work proposes a method that can not only handle drugs or diseases with or without related genes but consider the network modularity, and constructs a drug network and a disease network based on side effects and symptoms respectively.

Prediction of Drug Indications Based on Chemical Interactions and Chemical Similarities

Interestingly, some clinically repurposed drug indications that were not included in the datasets are successfully identified by the method, suggesting that the method may become a useful tool to associate novel molecules with new indications or alternative indications with existing drugs.

Target-Based Drug Repositioning Using Large-Scale Chemical-Protein Interactome Data

This study developed novel computational methods to predict potential drug targets and new drug indications for systematic drug repositioning using large-scale chemical-protein interactome data and conducted a comprehensive prediction of the drug-target-disease association network.

Systematic Drug Repositioning for a Wide Range of Diseases with Integrative Analyses of Phenotypic and Molecular Data

A new computational method to predict unknown drug indications for systematic drug repositioning in a framework of supervised network inference and shows that the proposed method outperforms previous methods in terms of accuracy and applicability, and its performance does not depend on drug chemical structure similarity.

Prediction of Drug-Disease Associations for Drug Repositioning Through Drug-miRNA-Disease Heterogeneous Network

The proposed miRNA-based computational method HNBI showed superior performance in drug-disease association predictions compared with two state-of-the-art methods and incorporated information of target miRNAs to understand the mechanisms of action of drugs and the molecular mechanisms of diseases.

DR2DI: a powerful computational tool for predicting novel drug-disease associations

  • Lu LuHua Yu
  • Biology
    Journal of Computer-Aided Molecular Design
  • 2018
A novel and powerful computational tool for accurately uncovering the potential associations between drugs and diseases using high-dimensional and heterogeneous omics data as information sources and can be served as a useful bioinformatic tool for identifying the potential drug-disease associations and guiding drug repositioning.

Overlap matrix completion for predicting drug-associated indications

Computational experiments on various datasets indicate that the OMC methods can effectively predict the potential drug–disease associations and case studies confirm the effectiveness of the methods in identifying promising indications for existing drugs in practical applications.

Drug Repositioning by Bipartite Local Models

A novel method named as BLMDR that use local models for both drugs and diseases presented in a bipartite network for inferring drug-disease associations that achieves reasonable prediction performance and outperforms a state-of-the-art global model-based prediction method.

DDIT: An Online Predictor for Multiple Clinical Phenotypic Drug-Disease Associations

Drug Disease Interaction Type (DDIT) is a user-friendly online predictor that supports drug repositioning by submitting known Is, SEs, and CIs for a target drug of interest and is a useful tool for predicting multiple clinical phenotypic types of drug–disease associations.

Drug Repositioning by Kernel-Based Integration of Molecular Structure, Molecular Activity, and Phenotype Data

A new method for drug repositioning, PreDR (Predict Drug Repositioning), to integrate molecular structure, molecular activity, and phenotype data is proposed and can serve as a useful tool in drug discovery to efficiently identify novel drug-disease interactions.



Prediction of potential drug targets based on simple sequence properties

A sequence-based drug target prediction method based solely on protein sequence information without the knowledge of family/domain annotation, or the protein 3D structure that can be applied in novel drug target identification and validation, as well as genome scale drug target predictions.

Combining Drug and Gene Similarity Measures for Drug-Target Elucidation

A novel framework--Similarity-based Inference of drug-TARgets (SITAR)--for incorporating multiple drug-drug and gene-gene similarity measures for drug target prediction and provides an extensible platform for incorporating additional emerging similarity measures among drugs and genes.

DrugBank: a knowledgebase for drugs, drug actions and drug targets

The latest version of DrugBank (release 2.0) has been expanded significantly over the previous release and contains 60% more FDA-approved small molecule and biotech drugs including 10% more ‘experimental’ drugs.

Human Disease-Drug Network Based on Genomic Expression Profiles

A systematic, large-scale analysis of genomic expression profiles of human diseases and drugs to create a large scale disease-drug network for effective and efficient drug repositioning as well as drug target/pathway identification.

An Algorithmic Framework for Predicting Side-Effects of Drugs

A novel approach to predict the side effects of a given drug starting from a query drug, a combination of canonical correlation analysis and network-based diffusion are applied to predict its side effects.

Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses

A drug treatment–based view of diseases was systematically evaluated and suggested novel drug uses generated using a “guilt by association” approach, which were significantly enriched with respect to previous and ongoing clinical trials.

An Algorithmic Framework for Predicting Side Effects of Drugs

A novel approach to predict the side effects of a given drug, taking into consideration information on other drugs and their side effects, is reported on, able to infer side effects that highly match existing knowledge.

SuperTarget and Matador: resources for exploring drug-target relationships

A one-stop data warehouse that integrates drug-related information about medical indication areas, adverse drug effects, drug metabolization, pathways and Gene Ontology terms of the target proteins and provides tools for 2D drug screening and sequence comparison of the targets.

Generating Genome‐Scale Candidate Gene Lists for Pharmacogenomics

A method that ranks 12,460 genes in the human genome on the basis of their potential relevance to a specific query drug and its putative indications, using known gene–drug interactions, networks of gene–gene interactions, and available measures of drug–drug similarity is developed.

Building Disease-Specific Drug-Protein Connectivity Maps from Molecular Interaction Networks and PubMed Abstracts

A computational framework to build disease-specific drug-protein connectivity maps based on protein interaction networks and literature mining was developed, showing that this molecular connectivity map development approach outperformed both curated drug target databases and conventional information retrieval systems.